載入...
Treatment of walking impairment in multiple sclerosis with dalfampridine
Potassium channel blockade has long been considered a potential therapeutic strategy for treatment of multiple sclerosis (MS) based on the pathophysiology of demyelinated axons. Dalfampridine, which is also known as fampridine or 4-aminopyridine (4-AP), is the potassium channel blocker that has been...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publishing
2011-03-01
|
| 叢編: | Therapeutic Advances in Neurological Disorders |
| 在線閱讀: | https://doi.org/10.1177/1756285611403960 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|